More individuals will gain access to HIV drugs and pre-exposure prophylaxis (PrEP) medication under the the Trump administration's new multi-agency Initiative to End the HIV Epidemic, via strategies such as increasing affordability of PrEP obtained through federally qualified community health centers.
HHS officials provided some specifics on the plan Feb. 6, following its unveiling in the president's State of the Union...






